|
Fusion gene ID: 22054 |
FusionGeneSummary for MITF_ARL6IP5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: MITF_ARL6IP5 | Fusion gene ID: 22054 | Hgene | Tgene | Gene symbol | MITF | ARL6IP5 | Gene ID | 4286 | 10550 |
Gene name | melanogenesis associated transcription factor | ADP ribosylation factor like GTPase 6 interacting protein 5 | |
Synonyms | CMM8|COMMAD|MI|WS2|WS2A|bHLHe32 | DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b|addicsin|hp22|jmx | |
Cytomap | 3p13 | 3p14.1 | |
Type of gene | protein-coding | protein-coding | |
Description | microphthalmia-associated transcription factorclass E basic helix-loop-helix protein 32microphtalmia-associated transcription factor | PRA1 family protein 3ADP-ribosylation factor GTPase 6 interacting protein 5ADP-ribosylation factor-like 6 interacting protein 5ADP-ribosylation factor-like protein 6-interacting protein 5ADP-ribosylation-like factor 6 interacting protein 5ARL-6-inter | |
Modification date | 20180527 | 20180519 | |
UniProtAcc | O75030 | O75915 | |
Ensembl transtripts involved in fusion gene | ENST00000352241, ENST00000448226, ENST00000472437, ENST00000328528, ENST00000314589, ENST00000394355, ENST00000314557, ENST00000394351, ENST00000531774, ENST00000394348, | ENST00000273258, ENST00000478935, | |
Fusion gene scores | * DoF score | 7 X 3 X 3=63 | 3 X 3 X 2=18 |
# samples | 5 | 3 | |
** MAII score | log2(5/63*10)=-0.333423733725192 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: MITF [Title/Abstract] AND ARL6IP5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MITF | GO:0010628 | positive regulation of gene expression | 22234890 |
Hgene | MITF | GO:0045893 | positive regulation of transcription, DNA-templated | 9647758 |
Hgene | MITF | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20530484|21209915 |
Hgene | MITF | GO:0065003 | protein-containing complex assembly | 20530484 |
Hgene | MITF | GO:2000144 | positive regulation of DNA-templated transcription, initiation | 8995290|12204775 |
Hgene | MITF | GO:2001141 | regulation of RNA biosynthetic process | 16411896 |
Tgene | ARL6IP5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 18387645 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | PRAD | TCGA-HC-8216-01A | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000352241 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
In-frame | ENST00000352241 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
In-frame | ENST00000448226 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
In-frame | ENST00000448226 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000472437 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000472437 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000328528 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000328528 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000314589 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000314589 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394355 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394355 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000314557 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000314557 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394351 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394351 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000531774 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000531774 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394348 | ENST00000273258 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
intron-3CDS | ENST00000394348 | ENST00000478935 | MITF | chr3 | 69788852 | + | ARL6IP5 | chr3 | 69150990 | + |
Top |
FusionProtFeatures for MITF_ARL6IP5 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MITF | ARL6IP5 |
Regulates intracellular concentrations of taurine andglutamate. Negatively modulates SLC1A1/EAAC1 glutamate transportactivity by decreasing its affinity for glutamate in a PKCactivity-dependent manner. May be involved in membrane traffic.{ECO:0000250|UniProtKB:Q8R5J9, ECO:0000250|UniProtKB:Q9ES40}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 103_117 | 58 | 189 | Region | Required for homodimer formation and heterodimer formation with ARL6IP1 |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 136_188 | 58 | 189 | Region | Targeting to endoplasmic reticulum membrane |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 78_93 | 58 | 189 | Topological domain | Cytoplasmic |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 115_135 | 58 | 189 | Transmembrane | Helical |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 57_77 | 58 | 189 | Transmembrane | Helical |
Tgene | >ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 94_114 | 58 | 189 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314557 | + | 1 | 9 | 355_402 | -46 | 414 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314589 | + | 1 | 10 | 355_402 | -4 | 505 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000328528 | + | 1 | 10 | 355_402 | -11 | 520 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000352241 | + | 1 | 10 | 355_402 | 34 | 521 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394351 | + | 1 | 9 | 355_402 | -40 | 420 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394355 | + | 1 | 9 | 355_402 | 0 | 496 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000448226 | + | 1 | 10 | 355_402 | 34 | 527 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000472437 | + | 1 | 10 | 355_402 | -63 | 469 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000531774 | + | 1 | 9 | 355_402 | 0 | 358 | Coiled coil | Ontology_term=ECO:0000305 |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314557 | + | 1 | 9 | 311_364 | -46 | 414 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314589 | + | 1 | 10 | 311_364 | -4 | 505 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000328528 | + | 1 | 10 | 311_364 | -11 | 520 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000352241 | + | 1 | 10 | 311_364 | 34 | 521 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394351 | + | 1 | 9 | 311_364 | -40 | 420 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394355 | + | 1 | 9 | 311_364 | 0 | 496 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000448226 | + | 1 | 10 | 311_364 | 34 | 527 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000472437 | + | 1 | 10 | 311_364 | -63 | 469 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000531774 | + | 1 | 9 | 311_364 | 0 | 358 | Domain | bHLH |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314557 | + | 1 | 9 | 224_295 | -46 | 414 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314557 | + | 1 | 9 | 374_395 | -46 | 414 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314557 | + | 1 | 9 | 401_431 | -46 | 414 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314589 | + | 1 | 10 | 224_295 | -4 | 505 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314589 | + | 1 | 10 | 374_395 | -4 | 505 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000314589 | + | 1 | 10 | 401_431 | -4 | 505 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000328528 | + | 1 | 10 | 224_295 | -11 | 520 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000328528 | + | 1 | 10 | 374_395 | -11 | 520 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000328528 | + | 1 | 10 | 401_431 | -11 | 520 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000352241 | + | 1 | 10 | 224_295 | 34 | 521 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000352241 | + | 1 | 10 | 374_395 | 34 | 521 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000352241 | + | 1 | 10 | 401_431 | 34 | 521 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394351 | + | 1 | 9 | 224_295 | -40 | 420 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394351 | + | 1 | 9 | 374_395 | -40 | 420 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394351 | + | 1 | 9 | 401_431 | -40 | 420 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394355 | + | 1 | 9 | 224_295 | 0 | 496 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394355 | + | 1 | 9 | 374_395 | 0 | 496 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000394355 | + | 1 | 9 | 401_431 | 0 | 496 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000448226 | + | 1 | 10 | 224_295 | 34 | 527 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000448226 | + | 1 | 10 | 374_395 | 34 | 527 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000448226 | + | 1 | 10 | 401_431 | 34 | 527 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000472437 | + | 1 | 10 | 224_295 | -63 | 469 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000472437 | + | 1 | 10 | 374_395 | -63 | 469 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000472437 | + | 1 | 10 | 401_431 | -63 | 469 | Region | Note=DNA binding regulation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000531774 | + | 1 | 9 | 224_295 | 0 | 358 | Region | Note=Transactivation |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000531774 | + | 1 | 9 | 374_395 | 0 | 358 | Region | Leucine-zipper |
Hgene | >MITF | chr3:69788852 | chr3:69150990 | ENST00000531774 | + | 1 | 9 | 401_431 | 0 | 358 | Region | Note=DNA binding regulation |
Tgene | ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 1_35 | 58 | 189 | Topological domain | Cytoplasmic |
Tgene | ARL6IP5 | chr3:69788852 | chr3:69150990 | ENST00000273258 | + | 0 | 3 | 36_56 | 58 | 189 | Transmembrane | Helical |
Top |
FusionGeneSequence for MITF_ARL6IP5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_165aa MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKSRFLSPFNMILGGIVVVLVFTGFVWAAHNKDVLRRMKKRYPTTFVMVVMLASYFLIS >In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_65aa >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_165aa MQSESGIVPDFEVGEEFHEEPKTYYELKSQPLKSRFLSPFNMILGGIVVVLVFTGFVWAAHNKDVLRRMKKRYPTTFVMVVMLASYFLIS >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_65aa |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_495nt ATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAA CCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACATGATCCTGGGAGGAATCGTGGTGGTGCTGGTGTTCACAGGGTTTGTGTGGGCAGCC CACAATAAAGACGTCCTTCGCCGGATGAAGAAGCGCTACCCCACGACGTTCGTTATGGTGGTCATGTTGGCGAGCTATTTCCTTATCTCC ATGTTTGGAGGAGTCATGGTCTTTGTGTTTGGCATTACTTTTCCTTTGCTGTTGATGTTTATCCATGCATCGTTGAGACTTCGGAACCTC AAGAACAAACTGGAGAATAAAATGGAAGGAATAGGTTTGAAGAGGACACCGATGGGCATTGTCCTGGATGCCCTAGAACAGCAGGAAGAA >In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_195nt ATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAA CCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACCCTCCTATTGTGTCTGAAGTTTCACGTGTGTTTATGAAATCTAATGGGAAATGGATC >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_495nt ATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAA CCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACATGATCCTGGGAGGAATCGTGGTGGTGCTGGTGTTCACAGGGTTTGTGTGGGCAGCC CACAATAAAGACGTCCTTCGCCGGATGAAGAAGCGCTACCCCACGACGTTCGTTATGGTGGTCATGTTGGCGAGCTATTTCCTTATCTCC ATGTTTGGAGGAGTCATGGTCTTTGTGTTTGGCATTACTTTTCCTTTGCTGTTGATGTTTATCCATGCATCGTTGAGACTTCGGAACCTC AAGAACAAACTGGAGAATAAAATGGAAGGAATAGGTTTGAAGAGGACACCGATGGGCATTGTCCTGGATGCCCTAGAACAGCAGGAAGAA >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_195nt ATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAA CCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACCCTCCTATTGTGTCTGAAGTTTCACGTGTGTTTATGAAATCTAATGGGAAATGGATC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_2088nt GTAAACTCCCCGCGCTGGGGCGGGCGGCCGCGAGCCGGCGAGCGGGCAGAGCTCGGCACTGCGCCGGGGCGCACGGCTCGGGGGACCCAG GCCCAGCTACCTTCCCTCCGCCCCCGGGCTCTGTTCTCACTTTCCAGCAGTGGAAGGACGGGAAGCGGGAGCCATGCAGTCCGAATCGGG GATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAACCGCTGAAGAGCAGGTT TCTGAGTCCCTTCAACATGATCCTGGGAGGAATCGTGGTGGTGCTGGTGTTCACAGGGTTTGTGTGGGCAGCCCACAATAAAGACGTCCT TCGCCGGATGAAGAAGCGCTACCCCACGACGTTCGTTATGGTGGTCATGTTGGCGAGCTATTTCCTTATCTCCATGTTTGGAGGAGTCAT GGTCTTTGTGTTTGGCATTACTTTTCCTTTGCTGTTGATGTTTATCCATGCATCGTTGAGACTTCGGAACCTCAAGAACAAACTGGAGAA TAAAATGGAAGGAATAGGTTTGAAGAGGACACCGATGGGCATTGTCCTGGATGCCCTAGAACAGCAGGAAGAAGGCATCAACAGACTCAC TGACTATATCAGCAAAGTGAAGGAATAAACATAACTTACCTGAGCTAGGGTTGCAGCAGAAATTGAGTTGCAGCTTGCCCTTGTCCAGAC CTATGTTCTGCTTGCGTTTTTGAAACAGGAGGTGCACGTACCACCCAATTATCTATGGCAGCATGCATGTATAGGCCGAACTATTATCAG CTCTGATGTTTCAGAGAGAAGACCTCAGAAACCGAAAGAAAACCACCACCCTCCTATTGTGTCTGAAGTTTCACGTGTGTTTATGAAATC TAATGGGAAATGGATCACACGATTTCTTTAAGGGAATTAAAAAAAATAAAAGAATTACGGCTTTTACAGCAACAATACGATTATCTTATA GGAAAAAAAAAATCATTGTAAAGTATCAAGACAATACGAGTAAATGAAAAGGCTGTTAAAGTAGATGACATCATGTGTTAGCCTGTTCCT AATCCCCTAGAATTGTAATGTGTGGGATATAAATTAGTTTTTATTATTCTCTTAAAAATCAAAGATGATCTCTATCACTTTGCCACCTGT TTGATGTGCAGTGGAAACTGGTTAAGCCAGTTGTTCATACTTCCTTTACAAATATAAAGATAGCTGTTTAGGATATTTTGTTACATTTTT GTAAATTTTTGAAATGCTAGTAATGTGTTTTCACCAGCAAGTATTTGTTGCAAACTTAATGTCATTTTCCTTAAGATGGTTACAGCTATG TAACCTGTATTATTCTGGACGGACTTATTAAAATACAAACAGACAAAAAATAAAACAAAACTTGAGTTCTATTTACCTTGCACATTTTTT GTTGTTACAGTGAAAAAAATGGTCCAAGAAAATGTTTGCCATTTTTGCATTGTTTCGTTTTTAACTGGAACATTTAGAAAGAAGGAAATG AATGTGCATTTTATTAATTCCTTAGGGGCACAAGGAGGACAATAATAGCTGATCTTTTGAAATTTGAAAAACGTCTTTAGATGACCAAGC AAAAAGACTTTAAAAAATGGTAATGAAAATGGAATGCAGCTACTGCAGCTAATAAAAAATTTTAGATAGCAATTGTTACAACCATATGCC TTTATAGCTAGACATTAGAATTATGATAGCATGAGTTTATACATTCTATTATTTTTCCTCCCTTTCTCATGTTTTTATAAATAGGTAATA AAAAATGTTTTGCCTGCCAATTGAATGATTTCGTAGCTGAAGTAGAAACATTTAGGTTTCTGTAGCATTAAATTGTGAAGACAACTGGAG TGGTACTTACTGAAGAAACTCTCTGTATGTCCTAGAATAAGAAGCAATGATGTGCTGCTTCTGATTTTTCTTGCATTTTAAATTCTCAGC CAACCTACAGCCATGATCTTTAGCACAGTGATATCACCATGACTTCACAGACATGGTCTAGAATCTGTACCCTTACCCACATATGAAGAA >In-frame_MITF_ENST00000352241_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_1513nt GTAAACTCCCCGCGCTGGGGCGGGCGGCCGCGAGCCGGCGAGCGGGCAGAGCTCGGCACTGCGCCGGGGCGCACGGCTCGGGGGACCCAG GCCCAGCTACCTTCCCTCCGCCCCCGGGCTCTGTTCTCACTTTCCAGCAGTGGAAGGACGGGAAGCGGGAGCCATGCAGTCCGAATCGGG GATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCATGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAACCGCTGAAGAGCAGGTT TCTGAGTCCCTTCAACCCTCCTATTGTGTCTGAAGTTTCACGTGTGTTTATGAAATCTAATGGGAAATGGATCACACGATTTCTTTAAGG GAATTAAAAAAAATAAAAGAATTACGGCTTTTACAGCAACAATACGATTATCTTATAGGAAAAAAAAAATCATTGTAAAGTATCAAGACA ATACGAGTAAATGAAAAGGCTGTTAAAGTAGATGACATCATGTGTTAGCCTGTTCCTAATCCCCTAGAATTGTAATGTGTGGGATATAAA TTAGTTTTTATTATTCTCTTAAAAATCAAAGATGATCTCTATCACTTTGCCACCTGTTTGATGTGCAGTGGAAACTGGTTAAGCCAGTTG TTCATACTTCCTTTACAAATATAAAGATAGCTGTTTAGGATATTTTGTTACATTTTTGTAAATTTTTGAAATGCTAGTAATGTGTTTTCA CCAGCAAGTATTTGTTGCAAACTTAATGTCATTTTCCTTAAGATGGTTACAGCTATGTAACCTGTATTATTCTGGACGGACTTATTAAAA TACAAACAGACAAAAAATAAAACAAAACTTGAGTTCTATTTACCTTGCACATTTTTTGTTGTTACAGTGAAAAAAATGGTCCAAGAAAAT GTTTGCCATTTTTGCATTGTTTCGTTTTTAACTGGAACATTTAGAAAGAAGGAAATGAATGTGCATTTTATTAATTCCTTAGGGGCACAA GGAGGACAATAATAGCTGATCTTTTGAAATTTGAAAAACGTCTTTAGATGACCAAGCAAAAAGACTTTAAAAAATGGTAATGAAAATGGA ATGCAGCTACTGCAGCTAATAAAAAATTTTAGATAGCAATTGTTACAACCATATGCCTTTATAGCTAGACATTAGAATTATGATAGCATG AGTTTATACATTCTATTATTTTTCCTCCCTTTCTCATGTTTTTATAAATAGGTAATAAAAAATGTTTTGCCTGCCAATTGAATGATTTCG TAGCTGAAGTAGAAACATTTAGGTTTCTGTAGCATTAAATTGTGAAGACAACTGGAGTGGTACTTACTGAAGAAACTCTCTGTATGTCCT AGAATAAGAAGCAATGATGTGCTGCTTCTGATTTTTCTTGCATTTTAAATTCTCAGCCAACCTACAGCCATGATCTTTAGCACAGTGATA >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000273258_chr3_69150990_+_2052nt GGCGAGCGGGCAGAGCTCGGCACTGCGCCGGGGCGCACGGCTCGGGGGACCCAGGCCCAGCTACCTTCCCTCCGCCCCCGGGCTCTGTTC TCACTTTCCAGCAGTGGAAGGACGGGAAGCGGGAGCCATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCA TGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAACCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACATGATCCTGGGAGGAATCGT GGTGGTGCTGGTGTTCACAGGGTTTGTGTGGGCAGCCCACAATAAAGACGTCCTTCGCCGGATGAAGAAGCGCTACCCCACGACGTTCGT TATGGTGGTCATGTTGGCGAGCTATTTCCTTATCTCCATGTTTGGAGGAGTCATGGTCTTTGTGTTTGGCATTACTTTTCCTTTGCTGTT GATGTTTATCCATGCATCGTTGAGACTTCGGAACCTCAAGAACAAACTGGAGAATAAAATGGAAGGAATAGGTTTGAAGAGGACACCGAT GGGCATTGTCCTGGATGCCCTAGAACAGCAGGAAGAAGGCATCAACAGACTCACTGACTATATCAGCAAAGTGAAGGAATAAACATAACT TACCTGAGCTAGGGTTGCAGCAGAAATTGAGTTGCAGCTTGCCCTTGTCCAGACCTATGTTCTGCTTGCGTTTTTGAAACAGGAGGTGCA CGTACCACCCAATTATCTATGGCAGCATGCATGTATAGGCCGAACTATTATCAGCTCTGATGTTTCAGAGAGAAGACCTCAGAAACCGAA AGAAAACCACCACCCTCCTATTGTGTCTGAAGTTTCACGTGTGTTTATGAAATCTAATGGGAAATGGATCACACGATTTCTTTAAGGGAA TTAAAAAAAATAAAAGAATTACGGCTTTTACAGCAACAATACGATTATCTTATAGGAAAAAAAAAATCATTGTAAAGTATCAAGACAATA CGAGTAAATGAAAAGGCTGTTAAAGTAGATGACATCATGTGTTAGCCTGTTCCTAATCCCCTAGAATTGTAATGTGTGGGATATAAATTA GTTTTTATTATTCTCTTAAAAATCAAAGATGATCTCTATCACTTTGCCACCTGTTTGATGTGCAGTGGAAACTGGTTAAGCCAGTTGTTC ATACTTCCTTTACAAATATAAAGATAGCTGTTTAGGATATTTTGTTACATTTTTGTAAATTTTTGAAATGCTAGTAATGTGTTTTCACCA GCAAGTATTTGTTGCAAACTTAATGTCATTTTCCTTAAGATGGTTACAGCTATGTAACCTGTATTATTCTGGACGGACTTATTAAAATAC AAACAGACAAAAAATAAAACAAAACTTGAGTTCTATTTACCTTGCACATTTTTTGTTGTTACAGTGAAAAAAATGGTCCAAGAAAATGTT TGCCATTTTTGCATTGTTTCGTTTTTAACTGGAACATTTAGAAAGAAGGAAATGAATGTGCATTTTATTAATTCCTTAGGGGCACAAGGA GGACAATAATAGCTGATCTTTTGAAATTTGAAAAACGTCTTTAGATGACCAAGCAAAAAGACTTTAAAAAATGGTAATGAAAATGGAATG CAGCTACTGCAGCTAATAAAAAATTTTAGATAGCAATTGTTACAACCATATGCCTTTATAGCTAGACATTAGAATTATGATAGCATGAGT TTATACATTCTATTATTTTTCCTCCCTTTCTCATGTTTTTATAAATAGGTAATAAAAAATGTTTTGCCTGCCAATTGAATGATTTCGTAG CTGAAGTAGAAACATTTAGGTTTCTGTAGCATTAAATTGTGAAGACAACTGGAGTGGTACTTACTGAAGAAACTCTCTGTATGTCCTAGA ATAAGAAGCAATGATGTGCTGCTTCTGATTTTTCTTGCATTTTAAATTCTCAGCCAACCTACAGCCATGATCTTTAGCACAGTGATATCA >In-frame_MITF_ENST00000448226_chr3_69788852_+_ARL6IP5_ENST00000478935_chr3_69150990_+_1477nt GGCGAGCGGGCAGAGCTCGGCACTGCGCCGGGGCGCACGGCTCGGGGGACCCAGGCCCAGCTACCTTCCCTCCGCCCCCGGGCTCTGTTC TCACTTTCCAGCAGTGGAAGGACGGGAAGCGGGAGCCATGCAGTCCGAATCGGGGATCGTGCCGGATTTCGAAGTCGGGGAGGAGTTTCA TGAAGAGCCCAAAACCTATTACGAACTCAAAAGTCAACCGCTGAAGAGCAGGTTTCTGAGTCCCTTCAACCCTCCTATTGTGTCTGAAGT TTCACGTGTGTTTATGAAATCTAATGGGAAATGGATCACACGATTTCTTTAAGGGAATTAAAAAAAATAAAAGAATTACGGCTTTTACAG CAACAATACGATTATCTTATAGGAAAAAAAAAATCATTGTAAAGTATCAAGACAATACGAGTAAATGAAAAGGCTGTTAAAGTAGATGAC ATCATGTGTTAGCCTGTTCCTAATCCCCTAGAATTGTAATGTGTGGGATATAAATTAGTTTTTATTATTCTCTTAAAAATCAAAGATGAT CTCTATCACTTTGCCACCTGTTTGATGTGCAGTGGAAACTGGTTAAGCCAGTTGTTCATACTTCCTTTACAAATATAAAGATAGCTGTTT AGGATATTTTGTTACATTTTTGTAAATTTTTGAAATGCTAGTAATGTGTTTTCACCAGCAAGTATTTGTTGCAAACTTAATGTCATTTTC CTTAAGATGGTTACAGCTATGTAACCTGTATTATTCTGGACGGACTTATTAAAATACAAACAGACAAAAAATAAAACAAAACTTGAGTTC TATTTACCTTGCACATTTTTTGTTGTTACAGTGAAAAAAATGGTCCAAGAAAATGTTTGCCATTTTTGCATTGTTTCGTTTTTAACTGGA ACATTTAGAAAGAAGGAAATGAATGTGCATTTTATTAATTCCTTAGGGGCACAAGGAGGACAATAATAGCTGATCTTTTGAAATTTGAAA AACGTCTTTAGATGACCAAGCAAAAAGACTTTAAAAAATGGTAATGAAAATGGAATGCAGCTACTGCAGCTAATAAAAAATTTTAGATAG CAATTGTTACAACCATATGCCTTTATAGCTAGACATTAGAATTATGATAGCATGAGTTTATACATTCTATTATTTTTCCTCCCTTTCTCA TGTTTTTATAAATAGGTAATAAAAAATGTTTTGCCTGCCAATTGAATGATTTCGTAGCTGAAGTAGAAACATTTAGGTTTCTGTAGCATT AAATTGTGAAGACAACTGGAGTGGTACTTACTGAAGAAACTCTCTGTATGTCCTAGAATAAGAAGCAATGATGTGCTGCTTCTGATTTTT CTTGCATTTTAAATTCTCAGCCAACCTACAGCCATGATCTTTAGCACAGTGATATCACCATGACTTCACAGACATGGTCTAGAATCTGTA |
Top |
FusionGenePPI for MITF_ARL6IP5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MITF | LEF1, PIAS3, PATZ1, UBE2I, TFE3, FOS, SPI1, PAX6, TFEC, SUMO1, PIAS1, PIAS2, PSMD14, MARK3, CDK2, ELAVL1, HINT1, APP, EPAS1, STUB1, HK3, EBP, EP300, XPO1, TFEB, RBM6, KLHL20, TRIM25 | ARL6IP5 | ARL6, SLC1A1, XRCC1, RPL5, MAX, USP9X, PARP4, NOC4L, CLN8, VKORC1, UBL4A, ATP4A, RNF185, DERL1, DERL2, ESYT1, ICAM2, ATP1B3, NPDC1, LPAR6, P2RY12, TMEM185A, RTN4, HTR3E, EVI2A, FAM134C, HTR3C, TCTN2, TCTN3, SCLT1, TMEM216, GYPB, S1PR2, C5AR2, TACR1, TSPAN2, FPR2, SLC6A5, RTN1, SLC22A9, LPAR1, TSPAN11, UPK1A, TMEM128, VIPR1, SLC6A15, PPP2R1A, SDHA, KRAS, NOTCH1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MITF_ARL6IP5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MITF_ARL6IP5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MITF | C3152204 | MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8 | 2 | CTD_human;ORPHANET;UNIPROT |
Hgene | MITF | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Hgene | MITF | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | MITF | C0011053 | Deafness | 1 | CTD_human |
Hgene | MITF | C0025202 | melanoma | 1 | CTD_human;HPO |
Hgene | MITF | C0078918 | Albinism, Oculocutaneous | 1 | CTD_human |
Hgene | MITF | C0151779 | Cutaneous Melanoma | 1 | CTD_human |
Hgene | MITF | C0391816 | Tietz syndrome | 1 | CTD_human;ORPHANET;UNIPROT |
Hgene | MITF | C0549567 | Pigmentation Disorders | 1 | CTD_human |
Hgene | MITF | C1860339 | WAARDENBURG SYNDROME, TYPE IIA | 1 | CTD_human;UNIPROT |
Hgene | MITF | C2700265 | Waardenburg Syndrome Type 2 | 1 | CTD_human;ORPHANET |
Tgene | ARL6IP5 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | ARL6IP5 | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |